CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Clinical trial NCT05013372 · UNKNOWN
Trial details
- NCT number
- NCT05013372
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.